Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fortunato Morabito

Showing results (151-160 of 302) with videos related to

Pageof 31
Sort By:
Cancers|October 13, 2021
Transcriptomic Analysis in Multiple Myeloma and Primary Plasma Cell Leukemia with t(11;14) Reveals Different Expression Patterns with Biological Implications in Venetoclax SensitivityKatia Todoerti, Elisa Taiana, Noemi Puccio, et al.
Chemotherapy|July 26, 2017
Disappearance of Bone Marrow Fibrosis in a Patient with Chronic Myeloid Leukemia Treated with DasatinibErnesto Vigna, Bruno Martino, Francesco Bacci, et al.
Tumori|November 11, 2003
Differences in transplant-related complications between hematologic malignancies and solid tumors receiving high-dose chemotherapy and autologous peripheral blood stem cell transplantationMassimo Martino, Fortunato Morabito, Giuseppe Console, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 4, 2011
Allogeneic stem cell transplantation in multiple myeloma relapsed after autograft: a multicenter retrospective study based on donor availabilityFrancesca Patriarca, Hermann Einsele, Francesco Spina, et al.
Cells|January 12, 2021
Antitumor Effects of PRIMA-1 and PRIMA-1<sup>Met</sup> (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?Paola Menichini, Paola Monti, Andrea Speciale, et al.
European Journal of Haematology|March 7, 2026
Management of Primary Refractory Diffuse Large B-Cell Lymphoma in Patients Unsuitable for CAR T-Cell TherapySantino Caserta, Enrica Antonia Martino, Mamdouh Skafi, et al.
Genes, Chromosomes & Cancer|April 8, 2014
Relevance of telomere/telomerase system impairment in early stage chronic lymphocytic leukemiaMirjam Hoxha, Sonia Fabris, Luca Agnelli, et al.
Leukemia Research|June 28, 2005
Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantationSara Galimberti, Edoardo Benedetti, Fortunato Morabito, et al.
European Journal of Haematology|December 26, 2025
Beyond PD-1: Mechanisms of Resistance to Checkpoint Blockade in Classical Hodgkin Lymphoma and Next-Generation Immune StrategiesSantino Caserta, Enrica Antonia Martino, Mamdouh Skafi, et al.
European Journal of Haematology|February 3, 2026
Frontline Therapy in Diffuse Large B-Cell Lymphoma: Evolving Standards, Biological Insights, and Future DirectionsMamdouh Skafi, Santino Caserta, Ernesto Vigna, et al.
Pageof 31

Showing results (151-160 of 302) with videos related to

Sort By:
Pageof 31
Cancers|October 13, 2021
Transcriptomic Analysis in Multiple Myeloma and Primary Plasma Cell Leukemia with t(11;14) Reveals Different Expression Patterns with Biological Implications in Venetoclax SensitivityKatia Todoerti, Elisa Taiana, Noemi Puccio, et al.
Chemotherapy|July 26, 2017
Disappearance of Bone Marrow Fibrosis in a Patient with Chronic Myeloid Leukemia Treated with DasatinibErnesto Vigna, Bruno Martino, Francesco Bacci, et al.
Tumori|November 11, 2003
Differences in transplant-related complications between hematologic malignancies and solid tumors receiving high-dose chemotherapy and autologous peripheral blood stem cell transplantationMassimo Martino, Fortunato Morabito, Giuseppe Console, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 4, 2011
Allogeneic stem cell transplantation in multiple myeloma relapsed after autograft: a multicenter retrospective study based on donor availabilityFrancesca Patriarca, Hermann Einsele, Francesco Spina, et al.
Cells|January 12, 2021
Antitumor Effects of PRIMA-1 and PRIMA-1<sup>Met</sup> (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?Paola Menichini, Paola Monti, Andrea Speciale, et al.
European Journal of Haematology|March 7, 2026
Management of Primary Refractory Diffuse Large B-Cell Lymphoma in Patients Unsuitable for CAR T-Cell TherapySantino Caserta, Enrica Antonia Martino, Mamdouh Skafi, et al.
Genes, Chromosomes & Cancer|April 8, 2014
Relevance of telomere/telomerase system impairment in early stage chronic lymphocytic leukemiaMirjam Hoxha, Sonia Fabris, Luca Agnelli, et al.
Leukemia Research|June 28, 2005
Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantationSara Galimberti, Edoardo Benedetti, Fortunato Morabito, et al.
European Journal of Haematology|December 26, 2025
Beyond PD-1: Mechanisms of Resistance to Checkpoint Blockade in Classical Hodgkin Lymphoma and Next-Generation Immune StrategiesSantino Caserta, Enrica Antonia Martino, Mamdouh Skafi, et al.
European Journal of Haematology|February 3, 2026
Frontline Therapy in Diffuse Large B-Cell Lymphoma: Evolving Standards, Biological Insights, and Future DirectionsMamdouh Skafi, Santino Caserta, Ernesto Vigna, et al.
Pageof 31